If you’re producing a product at a loss, you’re not going to be in business for very long. The bigger issue is that the treatments rely on companies to foot the cost of production for the promise of later profit. Cut the companies out, have medical centers manage production not-for-profit.
Let’s be perfectly clear: in no case would the pharmaceutical company be taking a loss. They just wouldn’t be making enough money.
Of course there is a cost to producing the therapy, maintaining equipment, training physicians; and the number of people who need this therapy is very small. So what? That just makes the therapy cost more per patient. Insurance premiums might go up a tiny bit, taxes might go up a tiny bit, depending on the healthcare system where you are.
If you’re producing a product at a loss, you’re not going to be in business for very long. The bigger issue is that the treatments rely on companies to foot the cost of production for the promise of later profit. Cut the companies out, have medical centers manage production not-for-profit.
Let’s be perfectly clear: in no case would the pharmaceutical company be taking a loss. They just wouldn’t be making enough money.
Of course there is a cost to producing the therapy, maintaining equipment, training physicians; and the number of people who need this therapy is very small. So what? That just makes the therapy cost more per patient. Insurance premiums might go up a tiny bit, taxes might go up a tiny bit, depending on the healthcare system where you are.
deleted by creator
If a therapy costs too much, insurance will no longer pay for it.
And when insurance decides not to pay for a therapy that is only used by a handful of people, there are often only a handful of complaints.